Inflammatory cytokines, cortisol, and anhedonia in patients with treatment-resistant depression after consecutive infusions of low-dose esketamine

A Randomized Controlled Trial of the Tumor Necrosis Factor Antagonist Infliximab for Treatment-Resistant Depression

Charles L. Raison, Robin E. Rutherford, Bobbi J. Woolwine et al. · JAMA Psychiatry · 2012 · 1.6K citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study

Vanina Popova, Ella Daly, Madhukar H. Trivedi et al. · American Journal of Psychiatry · 2019 · 872 citations · Full text

Pharmacy, Pharmacotherapy, Psychiatry +17

Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression

Ella Daly, Jaskaran Singh, Maggie Fedgchin et al. · JAMA Psychiatry · 2017 · 705 citations · Full text

Pharmacy, Pharmacotherapy, Psychiatry +16

Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide: Results of a Double-Blind, Randomized, Placebo-Controlled Study

Carla M. Canuso, Jaskaran Singh, Maggie Fedgchin et al. · American Journal of Psychiatry · 2018 · 665 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Intravenous Esketamine in Adult Treatment-Resistant Depression: A Double-Blind, Double-Randomization, Placebo-Controlled Study

Jaskaran Singh, Maggie Fedgchin, Ella Daly et al. · Biological Psychiatry · 2015 · 465 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17